TY - JOUR
T1 - Autonomic dysreflexia
T2 - Atypical complication from immediate release Tapentadol
AU - Diaz, Claudia
AU - Solyali, Veli
N1 - Includes bibliographical references
PY - 2021/3/16
Y1 - 2021/3/16
N2 - Neurological disorders are a ubiquitous part of our lives, and with innovative technological advancements there are increasing numbers of people being diagnosed with a variety of conditions. While these advances uncover the underlying pathological pro-cess, the requisite need to manage a patient’s condition necessitates renewed vigour in the realm of key therapeutics. This case study looks at a patient with a rare neurological condition, transverse myelitis (TM), and a complication that many spinal cord injury patients suffer, autonomic dysreflexia (AD). However, what makes this case unique is when the patient was administered with immediate-release Tapentadol, a synthetic opioid, the patient suffered more frequent and prolonged attacks of AD. The ex-ploration of the functional anatomy of TM as it applies to this case is highlighted, and how the role of Tapentadol was a causative agent in increasing the patient’s AD.
AB - Neurological disorders are a ubiquitous part of our lives, and with innovative technological advancements there are increasing numbers of people being diagnosed with a variety of conditions. While these advances uncover the underlying pathological pro-cess, the requisite need to manage a patient’s condition necessitates renewed vigour in the realm of key therapeutics. This case study looks at a patient with a rare neurological condition, transverse myelitis (TM), and a complication that many spinal cord injury patients suffer, autonomic dysreflexia (AD). However, what makes this case unique is when the patient was administered with immediate-release Tapentadol, a synthetic opioid, the patient suffered more frequent and prolonged attacks of AD. The ex-ploration of the functional anatomy of TM as it applies to this case is highlighted, and how the role of Tapentadol was a causative agent in increasing the patient’s AD.
KW - Spinal cord injury
KW - Transverse myelitis
KW - Pharmacokinetics
KW - Opioids
U2 - 10.17140/TFMOJ-6-136
DO - 10.17140/TFMOJ-6-136
M3 - Article
VL - 6
SP - 9
EP - 12
JO - Toxicology and Forensic Medicine
JF - Toxicology and Forensic Medicine
SN - 2474-8978
IS - 1
ER -